ITPR3 and head and neck squamous cell carcinoma: Whole-exome sequencing (WES) conducted by Hedberg et al. in patients with head and neck squamous cell carcinoma (HNSCC) underpinned the potential clinical utility of IP3R3 as a prognostic biomarker.